The Journal of Allergy and Clinical Immunology
Volume 125, Issue 1 , Pages 60-68 , January 2010

Natural killer cells in atopic and autoimmune diseases of the skin

  • Dagmar von Bubnoff, MD

      Affiliations

    • Department of Dermatology and Allergy, Friedrich-Wilhelms-University, Bonn, Germany
    • ,
  • Emmanuel Andrès, MD

      Affiliations

    • Department of Internal Medicine, Medical Clinic B, University Hospitals of Strasbourg, Strasbourg, France
    • ,
  • François Hentges, MD

      Affiliations

    • Laboratory of Immunogenetics and Allergology, Centre de Recherche Public de la Santé (CRP-Santé), Luxembourg City, Luxembourg
    • ,
  • Thomas Bieber, MD

      Affiliations

    • Department of Dermatology and Allergy, Friedrich-Wilhelms-University, Bonn, Germany
    • ,
  • Tatiana Michel, PhD

      Affiliations

    • Laboratory of Immunogenetics and Allergology, Centre de Recherche Public de la Santé (CRP-Santé), Luxembourg City, Luxembourg
    • ,
  • Jacques Zimmer, MD, PhD

      Affiliations

    • Laboratory of Immunogenetics and Allergology, Centre de Recherche Public de la Santé (CRP-Santé), Luxembourg City, Luxembourg
    • Corresponding Author InformationReprint requests: Jacques Zimmer, MD, PhD, Laboratory of Immunogenetics and Allergology, Centre de Recherche Public de la Santé (CRP-Santé), 84 Val Fleuri, L-1526 Luxembourg.

Received 4 November 2009 ,Accepted 4 November 2009.

References 

  1. Smyth MJ, Hayakawa Y, Takeda K, Yagita H. New aspects of natural-killer-cell surveillance and therapy of cancer. Nat Rev Immunol. 2002;2:850–861
  2. Carayannopoulos LN, Yokoyama WM. Recognition of infected cells by natural killer cells. Curr Opin Immunol. 2004;16:26–33
  3. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nat Immunol. 2008;9:503–510
  4. Caligiuri MA. Human natural killer cells. Blood. 2008;112:461–469
  5. Cooper MA, Colonna M, Yokoyama WM. Hidden talents of natural killers: NK cells in innate and adaptive immunity. EMBO Rep. 2009;10:1103–1110
  6. Poli A, Michel T, Thérésine M, Andrès E, Hentges F, Zimmer J. CD56bright natural killer (NK) cells: an important NK cell subset. Immunology. 2009;126:458–465
  7. Moretta A. Natural killer cells and dendritic cells: rendezvous in abused tissues. Nat Rev Immunol. 2002;2:957–964
  8. Degli-Esposti MA, Smyth MJ. Close encounters of different kinds: dendritic cells and NK cells take center stage. Nat Rev Immunol. 2005;5:112–124
  9. Yokoyama WM, Kim S, French AR. The dynamic life of natural killer cells. Ann Rev Immunol. 2004;22:405–429
  10. Martin-Fontecha A, Thomsen LL, Brett S, Gerard C, Lipp M, Lanzavecchia A, et al. Induced recruitment of NK cells to lymph nodes provides IFN-γ for TH1 priming. Nat Immunol. 2004;5:1260–1265
  11. Assarsson E, Kambayashi T, Schatzle JD, Cramer SO, von Bonin A, Jensen P, et al. NK cells stimulate proliferation of T and NK cells through 2B4/CD48 interactions. J Immunol. 2004;173:174–180
  12. Zingoni A, Sornasse T, Cooks BG, Tanaka Y, Santoni A, Lanier LL. Cross-talk between activated human NK cells and CD4+ T cells via OX40-OX40 ligand interactions. J Immunol. 2004;173:3716–3724
  13. Lanier LL. NK cell recognition. Annu Rev Immunol. 2005;23:2225–2274
  14. O'Connor GM, Hart OM, Gardiner CM. Putting the natural killer cell in its place. Immunology. 2006;117:1–10
  15. Raulet DH. Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol. 2003;3:781–790
  16. Moretta A, Bottino C, Vitale M, Pende D, Cantoni C, Mingari MC, et al. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol. 2001;19:197–233
  17. Mandelboim O, Lieberman N, Lev M, Paul T, Arnon TI, Bushkin Y, et al. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature. 2001;409:1055–1060
  18. Arnon TI, Lev M, Katz G, Chernobrov Y, Porgador A, Mandelboim O. Recognition of viral hemagglutinins by NKp44 but not NKp30. Eur J Immunol. 2001;31:2680–2689
  19. Arnon TI, Achdout H, Levi O, Merkel G, Saleh N, Katz G, et al. Inhibition of the NKp30 activating receptor by pp65 from human cytomegalovirus. Nat Immunol. 2005;6:515–523
  20. Ferlazzo G, Tsang ML, Moretta L, Melioli G, Steinman RM, Münz C. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J Exp Med. 2002;195:343–351
  21. Brandt CS, Baratin M, Yi EC, Kennedy J, Gao Z, Fox B, et al. The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans. J Exp Med. 2009;206:1495–1503
  22. Fernandez NC, Treiner E, Vance RE, Jamieson AM, Lemieux S, Raulet DH. A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors for self-MHC molecules. Blood. 2005;105:4416–4423
  23. Kim S, Poursine-Laurent J, Truscott SM, Lybarger L, Song YJ, Yang L, et al. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature. 2005;436:709–714
  24. Raulet DH, Vance RE. Self-tolerance of natural killer cells. Nat Rev Immunol. 2006;6:520–531
  25. Anfossi N, André P, Guia S, Falk CS, Roetynck S, Stewart CA, et al. Human NK cell education by inhibitory receptors for MHC class I. Immunity. 2006;25:331–342
  26. Anderson SK, Ortaldo JR, McVicar DW. The ever-expanding Ly49 gene family: repertoire and signaling. Immunol Rev. 2001;181:79–89
  27. Kane KP, Silver ET, Hazes B. Specificity and function of activating Ly-49 receptors. Immunol Rev. 2001;181:104–114
  28. Perritt D, Robertson S, Gri G, Showe L, Aste-Amezaga M, Trinchieri G. Cutting edge: Differentiation of human NK cells into NK1 and NK2 subsets. J Immunol. 1998;161:5821–5824
  29. Fehniger TA, Shah MH, Turner MJ, Vandeusen JB, Whitman SP, Cooper MA, et al. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response. J Immunol. 1999;162:4511–4520
  30. Loza MJ, Zamai L, Azzoni L, Rosati E, Perussia B. Expression of type 1 (interferon gamma) and type 2 (interleukin-13, interleukin-5) cytokines at distinct stages of natural killer cell differentiation from progenitor cells. Blood. 2002;99:1273–1281
  31. Zhou R, Wei H, Tian Z. NK3-like NK cells are involved in protective effect of polyinosinic-polycytidylic acid on type 1 diabetes in nonobese diabetic mice. J Immunol. 2007;178:2141–2147
  32. Zhang C, Zhang J, Tian Z. The regulatory effect of natural killer cells: do “NK-reg cells” exist?. Cell Mol Immunol. 2006;3:241–254
  33. Brillard E, Pallandre JR, Chalmers D, Ryffel B, Radlovic A, Seilles E, et al. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4 + CD25- T lymphocytes. Exp Hematol. 2007;35:416–425
  34. Maroof A, Beattie L, Zubairi S, Svensson M, Stager S, Kaye PM. Posttranscriptional regulation of ll10 gene expression allows natural killer cells to express immunoregulatory function. Immunity. 2008;29:295–305
  35. Deniz G, Erten G, Kücüksezer UC, Kocacik D, Karagiannidis C, Aktas E, et al. Regulatory NK cells suppress antigen-specific T cell responses. J Immunol. 2008;180:850–857
  36. Kheradmand T, Trivedi PP, Wolf NA, Roberts PC, Swanborg RH. Characterization of a subset of bone marrow-derived natural killer cells that regulates T cell activation in rats. J Leukoc Biol. 2008;83:1128–1135
  37. Lo CK, Lam QL, Sun L, Wang S, Ko KH, Xu H, et al. Natural killer cell degeneration exacerbates experimental arthritis in mice via enhanced interleukin-17 production. Arthritis Rheum. 2008;58:2700–2711
  38. Giuliani M, Giron-Michel J, Negrini S, Vacca P, Durali D, Caignard A, et al. Generation of a novel regulatory NK cell subset from peripheral blood CD34+ progenitors promoted by membrane-bound IL-15. PLoS ONE. 2008;3:e2241
  39. Roy S, Barnes PF, Garg A, Wu S, Cosman D, Vankayalapati R. NK cells lyse regulatory T cells that expand in response to an intracellular pathogen. J Immunol. 2008;180:1729–1736
  40. Colonna M. Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity. Immunity. 2009;31:15–23
  41. Zenewicz LA, Flavell RA. IL-22 and inflammation: leukin' through a glass onion. Eur J Immunol. 2008;38:3265–3268
  42. Roark CL, Simonian PL, Fontenot AP, Born WK, O'Brien RL. γδ T cells: an important source of IL-17. Curr Opin Immunol. 2008;20:353–357
  43. Benghiat FS, Charbonnier LM, Vokaer B, De Wilde V, Le Moine A. Interleukin 17-producing T helper cells in alloimmunity. Transplant Rev. 2009;23:11–18
  44. Louten J, Boniface K, de Waal Malefyt R. Development and function of TH17 cells in health and disease. J Allergy Clin Immunol. 2009;123:1004–1011
  45. Hanna J, Gonen-Gross T, Fitchett J, Rowe T, Daniels M, Arnon TI, et al. Novel APC-like properties of human NK cells directly regulate T cell activation. J Clin Invest. 2004;114:1612–1623
  46. O'Leary JG, Goodarzi M, Drayton DL, von Andrian UH. T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat Immunol. 2006;7:507–516
  47. Sun JC, Beilke JN, Lanier LL. Adaptive immune features of natural killer cells. Nature. 2009;457:557–561
  48. Cooper MA, Elliott JM, Keyel PA, Yang L, Carrero JA, Yokoyama WM. Cytokine-induced memory-like natural killer cells. Proc Natl Acad Sci U S A. 2009;106:1915–1919
  49. Bieber T. Atopic dermatitis. N Engl J Med. 2008;358:1483–1494
  50. Elias PM, Hatano Y, Williams ML. Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms. J Allergy Clin Immunol. 2008;121:1337–1343
  51. Sandilands A, Terron-Kwiatkowski A, Hull PR, O'Regan GM, Clayton TH, Watson RM, et al. Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema. Nat Genet. 2007;39:650–654
  52. Akkoc T, de Koning PJ, Ruckert B, Barlan I, Akdis M, Akdis CA. Increased activation-induced cell death of high IFN-gamma-producing T(H)1 cells as a mechanism of T(H)2 predominance in atopic diseases. J Allergy Clin Immunol. 2008;121:652–658e1
  53. von Bubnoff D, Geiger E, Bieber T. Antigen-presenting cells in allergy. J Allergy Clin Immunol. 2001;108:329–339
  54. Nograles KE, Zaba LC, Shemer A, Fuentes-Duculan J, Cardinale I, Kikuchi T, et al. IL-22-producing “T22” T cells account for the upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells. J Allergy Clin Immunol. 2009;123:1244–1252e2
  55. Koga C, Kabashima K, Shiraishi N, Kobayashi M, Tokura K. Possible pathogenic role of Th17 cells for atopic dermatitis. J Invest Dermatol. 2008;128:2625–2630
  56. Toda M, Leung DY, Molet S, Boguniewicz M, Taha R, Christodoulopoulos P, et al. Polarized in vivo expression of IL-11 and IL-17 between acute and chronic skin lesions. J Allergy Clin Immunol. 2003;111:875–881
  57. Oyoshi MK, He R, Kumar L, Yoon S, Geha RS. Cellular and molecular mechanisms in atopic dermatitis. Adv Immunol. 2009;102:135–226
  58. Wollenberg A, Klein E. Current aspects of innate and adaptive immunity in atopic dermatitis. Clin Rev Allergy Immunol. 2007;33:35–44
  59. Wollenberg A, Kraft S, Hanau D, Bieber T. Immunomorphological and ultrastructural characterization of Langerhans cells and a novel, inflammatory dendritic epidermal cell (IDEC) population in lesional skin of atopic eczema. J Invest Dermatol. 1996;106:446–453
  60. Wollenberg A, Mommaas M, Oppel T, Schottdorf EM, Günther S, Moderer M. Expression and function of the mannose receptor CD206 on epidermal dendritic cells in inflammatory skin diseases. J Invest Dermatol. 2002;118:327–334
  61. Fallon PG, Sasaki T, Sandilands A, Campbell LE, Saunders SP, Mangan NE, et al. A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming. Nat Genet. 2009;41:602–608
  62. Kerschenlohr K, Decard S, Przybilla B, Wollenberg A. Atopy patch test reactions show a rapid influx of inflammatory dendritic epidermal cells in patients with extrinsic atopic dermatitis and patients with intrinsic atopic dermatitis. J Allergy Clin Immunol. 2003;111:869–874
  63. Novak N, Valenta R, Bohle B, Laffer S, Haberstok J, Kraft S, et al. FcepsilonRI engagement of Langerhans cell-like dendritic cells and inflammatory dendritic epidermal cell-like dendritic cells induces chemotactic signals and different T-cell phenotypes in vitro. J Allergy Clin Immunol. 2004;113:949–957
  64. Trifari S, Kaplan CD, Tran EH, Crellin NK, Spits H. Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)17, T(H)1 and T(H)2 cells. Nat Immunol. 2009;10:864–871
  65. Duhen T, Geiger R, Jarrossay D, Lanzavecchia A, Sallusto F. Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat Immunol. 2009;10:857–863
  66. Nograles KE, Zaba LC, Guttman-Yassky E, Fuentes-Duculan J, Suárez-Farinãs M, Cardinale I, et al. Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways. Br J Dermatol. 2008;159:1092–1102
  67. Howell MD, Wollenberg A, Gallo RL, Flaig M, Streib JE, Wong C, et al. Cathelicidin deficiency predisposes to eczema herpeticum. J Allergy Clin Immunol. 2006;117:836–841
  68. Kisich KO, Carspecken CW, Fieve S, Boguniewicz M, Leung DY. Defective killing of Staphylococcus aureus in atopic dermatitis is associated with reduced mobilization of human beta-defensin-3. J Allergy Clin Immunol. 2008;122:62–68
  69. Rieg S, Steffen H, Seeber S, Humeny A, Kalbacher H, Dietz K, et al. Deficiency of dermicidin-derived antimicrobial peptides in sweat of patients with atopic dermatitis correlates with an impaired innate defense of human skin in vivo. J Immunol. 2005;174:8003–8010
  70. Weaver CT, Hatton RD, Mangan PR, Harrington LE. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol. 2007;25:821–852
  71. Eyerich K, Foerster S, Rombold S, Seidl HP, Behrendt H, Hofmann H, et al. Patients with chronic mucocutaneous candidiasis exhibit reduced production of Th17-associated cytokines IL-17 and IL-22. J Invest Dermatol. 2008;128:2640–2645
  72. Luci C, Reynders A, Ivanov I, Cognet C, Chiche L, Chasson L, et al. Influence of the transcription factor RORgammaT on the development of NKp46+ cell populations in gut and skin. Nat Immunol. 2009;10:75–82
  73. Satoh-Takayama N, Vosshenrich CA, Lesjean-Potier S, Sawa S, Lochner M. Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity. 2008;29:958–970
  74. Cella M, Fuchs A, Vermi W, Facchetti F, Otero K, Lennerz JK, et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature. 2009;457:722–725
  75. Vivier E, Spits H, Cupedo T. Interleukin-22-producing innate immune cells: new players in mucosal immunity and tissue repair?. Nat Rev Immunol. 2009;9:229–234
  76. Buentke E, Heffler LC, Wilson JL, Wallin RP, Lofman C, Chambers BJ, et al. Natural killer and dendritic cell contact in lesional atopic dermatitis skin— Malassezia-influenced cell interaction. J Invest Dermatol. 2002;119:850–857
  77. Kawakami Y, Tomimuri Y, Yumoto K, Hasegawa S, Ando T, Tagaya Y, et al. Inhibition of NK cell activity by IL-17 allows vaccinia virus to induce severe skin lesions in a mouse model of eczema vaccinatum. J Exp Med. 2009;206:1219–1225
  78. Shimada Y, Sato S, Hasegawa M, Tedder TF, Takehara K. Elevated serum L-selectin levels and abnormal regulation of L-selectin expression on leukocytes in atopic dermatitis: soluble L-selectin levels indicate disease severity. J Allergy Clin Immunol. 1999;104:163–168
  79. Homey B, Meller S, Savinko T, Alenius H, Lauerma A. Modulation of chemokines by staphylococcal superantigen in atopic dermatitis. Chem Immunol Allergy. 2007;93:181–194
  80. Purwar R, Werfel T, Wittmann M. IL-13-stimulated human keratinocytes preferentially attract CD4 + CCR4 + T cells: possible role in atopic dermatitis. J Invest Dermatol. 2006;126:1043–1051
  81. Campbell DE, Fryga AS, Bol S, Kemp AS. Intracellular interferon-gamma (IFN-gamma) production in normal children and children with atopic dermatitis. Clin Exp Immunol. 1999;115:377–382
  82. Schmid-Ott G, Jaeger B, Adamek C, Koch H, Lamprecht F, Kapp A, et al. Levels of circulating CD8(+) T lymphocytes, natural killer cells, and eosinophils increase upon acute psychosocial stress in patients with atopic dermatitis. J Allergy Clin Immunol. 2001;107:171–177
  83. Katsuta M, Takigawa Y, Kimishima M, Inaoka M, Takahashi R, Shiohara T. NK cells and gamma delta+ T cells are phenotypically and functionally defective due to preferential apoptosis in patients with atopic dermatitis. J Immunol. 2006;176:7736–7744
  84. Schuster M, Tschernig T, Krug N, Pabst R. Lymphocytes migrate from the blood into the bronchoalveolar lavage and lung parenchyma in the asthma model of the brown Norway rat. Am J Respir Crit Care Med. 2000;161:558–566
  85. Walker C, Checkel J, Cammisuli S, Leibson PJ, Gleich GJ. IL-5 production by NK cells contributes to eosinophil infiltration in a mouse model of allergic inflammation. J Immunol. 1998;161:1962–1969
  86. Lambiase A, Normando EM, Vitiello L, Micera A, Sacchetti M, Perrella E, et al. Natural killer cells in vernal keratoconjunctivitis. Mol Vis. 2007;13:1562–1567
  87. Schmid-Ott G, Jaeger B, Adamek C, Koch H, Lamprecht F, Kapp A, et al. Levels of circulating CD8(+) T lymphocytes, natural killer cells, and eosinophils increase upon acute psychosocial stress in patients with atopic dermatitis. J Allergy Clin Immunol. 2001;107:171–177
  88. Aktas E, Akdis M, Bilgic S, Disch R, Falk CS, Blaser K, et al. Different natural killer (NK) receptor expression and immunoglobulin E (IgE) regulation by NK1 and NK2 cells. Clin Exp Immunol. 2005;140:301–309
  89. Koning H, Baert MR, Oranje AP, Savelkoul HF, Neijens HJ. Development of immune functions related to allergic mechanisms in young children. Pediatr Res. 1996;40:363–375
  90. Liao SY, Liao TN, Chiang BL, Huang MS, Chen CC, Chou CC, et al. Decreased production of IFN gamma and increased production of IL-6 by cord blood mononuclear cells of newborns with a high risk of allergy. Clin Exp Allergy. 1996;26:397–405
  91. Grégoire C, Chasson L, Luci C, Tomasello E, Geissmann F, Vivier E. The trafficking of natural killer cells. Immunol Rev. 2007;220:169–182
  92. Kimura K, Isowa T, Matsunaga M, Murashima S, Ohira H. The temporal redistribution pattern of NK cells under acute stress based on CD62L adhesion molecule expression. Int J Psychophysiol. 2008;70:63–69
  93. Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med. 2009;361:456–509
  94. McGonagle D, McDermott MF. A proposed classification of the immunological diseases. PLoS Med. 2006;3:e297
  95. Zaba LC, Fuentes-Duculan J, Eungdamrong NJ, Abello MV, Novitskaya I, Pierson KC, et al. Psoriasis is characterized by accumulation of immunostimulatory and Th1/Th17 cell-polarizing myeloid dendritic cells. J Invest Dermatol. 2009;129:79–88
  96. Boniface K, Bernard FX, Garcia M, Gurney AL, Lecron JC, Morel F. IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J Immunol. 2005;174:3695–3702
  97. Liang SC, Tan XY, Luxenberg DP, Karim R, Dunussi-Joannopoulos K, Collins M, et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med. 2006;203:2271–2279
  98. Lowes MA, Kikuchi T, Fuentes-Duculan J, Cardinale I, Zaba LC, Haider AS, et al. Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol. 2008;128:1207–1211
  99. Zheng Y, Danilenko DM, Valdez P, Kasman I, Eastham-Anderson J, Wu J, et al. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature. 2007;445:648–651
  100. Boniface K, Blom B, Liu YJ. de Waal Malefyt R. From interleukin-23 to T-helper 17 cells: human T-helper cell differentiation revisited. Immunol Rev. 2008;226:132–146
  101. Nickoloff BJ. The cytokine network in psoriasis. Arch Dermatol. 1991;127:871–884
  102. Reich K, Nestle FO, Papp K, Ortonne JP, Evans R, Guzzo C, et al. Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial. Lancet. 2005;366:1367–1374
  103. Bos JD, de Rie MA, Teunissen MB, Piskin G. Psoriasis: dysregulation of innate immunity. Br J Dermatol. 2005;152:1098–1107
  104. de Cid R, Riveira-Munoz E, Zeeuwen PL, Robarge J, Liao W, Dannhauser EN, et al. Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis. Nat Genet. 2009;41:211–215
  105. Gilhar A, Ullmann Y, Kerner H, Assy B, Shalaginov R, Serafimovich S, et al. Psoriasis is mediated by a cutaneous defect triggered by activated immunocytes: induction of psoriasis by cells with natural killer receptors. J Invest Dermatol. 2002;119:384–391
  106. Cameron AL, Kirby B, Fei W, Griffiths CE. Natural killer and natural killer-T cells in psoriasis. Arch Dermatol Res. 2002;294:363–369
  107. Ottaviani C, Nasorri F, Bedini C, de Pita O, Girolomoni G, Cavani A. CD56brightCD16(-) NK cells accumulate in psoriatic skin in response to CXCL10 and CCL5 and exacerbate skin inflammation. Eur J Immunol. 2006;36:118–128
  108. Cameron AL, Kirby B, Griffiths CE. Circulating natural killer cells in psoriasis. Br J Dermatol. 2003;149:160–164
  109. Riccieri V, Spadaro A, Parisi G, Taccari E, Moretti T, Bernardini G, et al. Down-regulation of natural killer cells and of gamma/delta T cells in systemic lupus erythematosus. Does it correlate to autoimmunity and to laboratory indices of disease activity?. Lupus. 2000;9:333–337
  110. La Gruta NL, Van Driel IR, Toh BH, Gleeson PA. The role of natural killer cells in the induction of autoimmune gastritis. Autoimmunity. 2001;34:147–154
  111. Brodin P, Karre K, Hoglund P. NK cell education: not an on-off switch but a tunable rheostat. Trends Immunol. 2009;30:143–149
  112. Rückert R, Hofmann U, van der Veen C, Bufone-Paus S, Paus R. MHC class I expression in murine skin: developmentally controlled and strikingly restricted intraepithelial expression during hair follicle morphogenesis and cycling, and response to cytokine treatment in vivo. J Invest Dermatol. 1998;111:25–30
  113. Paus R, Ito N, Takigawa M, Ito T. The hair follicle and immune privilege. J Investig Dermatol Symp Proc. 2003;8:188–194
  114. Gilhar A, Kalish RS. Alopecia areata: a tissue specific autoimmune disease of the hair follicle. Autoimmun Rev. 2006;5:64–69
  115. Cetin ED, Savk E, Uslu M, Eskin M, Karul A. Investigation of the inflammatory mechanisms in alopecia areata. Am J Dermatopathol. 2009;31:53–60
  116. Christoph T, Muller-Rover S, Audring H, Tobin DJ, Hermes B, Cotsarelis G, et al. The human hair follicle immune system: cellular composition and immune privilege. Br J Dermatol. 2000;142:862–873
  117. Ito T, Ito N, Bettermann A, Tokura Y, Takigawa M, Paus R. Collapse and restoration of MHC class-I-dependent immune privilege: exploiting the human hair follicle as a model. Am J Pathol. 2004;164:623–634
  118. Ito T, Ito N, Saathoff M, Stampachiacchiere B, Bettermann A, Bufone-Paus S, et al. Immunology of the human nail apparatus: the nail matrix is a site of relative immune privilege. J Invest Dermatol. 2005;125:1139–1148
  119. Kalkunte SS, Mselle TF, Norris WE, Wira CR, Sentman CL, Sharma B. Vascular endothelial growth factor C facilitates immune tolerance and endovascular activity of human uterine NK cells at the maternal-fetal interface. J Immunol. 2009;182:4085–4092
  120. Ranki A, Kianto U, Kanerva L, Tolvanen E, Johansson E. Immunohistochemical and electron microscopic characterization of the cellular infiltrate in alopecia (areata, totalis, and universalis). J Invest Dermatol. 1984;83:7–11
  121. Chiarini C, Torchia D, Bianchi B, Volpi W, Caproni M, Fabbri P. Immunopathogenesis of folliculitis decalvans: clues in early lesions. Am J Clin Pathol. 2008;130:526–534
  122. Ito T, Ito N, Saatoff M, Hashizume H, Fukamizu H, Nickoloff BJ, et al. Maintenance of hair follicle immune privilege is linked to prevention of NK cell attack. J Invest Dermatol. 2008;128:1196–1206
  123. Freyschmidt-Paul P, McElwee KJ, Hoffmann R, Sundberg JP, Vitacolonna M, Kissling S, et al. Interferon-gamma-deficient mice are resistant to the development of alopecia areata. Br J Dermatol. 2006;155:515–521
  124. Baadsgaard O, Lindskov R. Circulating lymphocyte subsets in patients with alopecia areata. Acta Derm Venereol. 1986;66:266–268
  125. Takahashi H, Amagai M, Tanikawa A, Suzuki S, Ikeda Y, Nishikawa N, et al. T helper type 2-biased natural killer cell phenotype in patients with pemphigus vulgaris. J Invest Dermatol. 2007;127:324–330
  126. Stern JNH, Keskin DB, Barteneva N, Zuniga J, Yunis EJ, Ahmed AR. Possible role of natural killer cells in pemphigus vulgaris—preliminary observations. Clin Exp Immunol. 2008;152:472–481
  127. Alecu M, Ursaciuc C, Surcel M, Coman G, Ciotaru D, Dobre M. CD28 T-cell costimulatory molecule expression in pemphigus vulgaris. J Eur Acad Dermatol Venereol. 2009;23:288–291

 Supported by grants from the Ministry of Culture, Higher Education, and Research (MCESR), Luxembourg, and the National Research Fund (FNR), Luxembourg.

 Disclosure of potential conflict of interest: F. Hentges receives research support from Fonds National de la Recherche. J. Zimmer receives research support from Ministry of Research (Luxembourg) and Fonds National de la Recherche (Luxembourg). All other authors declare no conflicts of interest.

PII: S0091-6749(09)01737-0

doi: 10.1016/j.jaci.2009.11.020

The Journal of Allergy and Clinical Immunology
Volume 125, Issue 1 , Pages 60-68 , January 2010

Article Tools